HBM Healthcare Investments
HBM Healthcare Investments
About
Listed on SIX Swiss Exchange (HBMN), HBM Healthcare Investments is a Swiss investment company holding a well-balanced globally diversified portfolio of investments in private and public healthcare companies.
Key facts
- Website
- hbmpartners.com
- Type
- Investment Firm
- Headquarters
- Switzerland
- Funds raised
- $3.0B
- Portfolio companies
- 9
- Stages
- Series ASeries BSeries C
- Cheque size
- $56M to $333M
- Sector focus
- HealthcareDrug DevelopmentGenomicsNext Generation SequencingBiotech
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 6 May 2026 | CellCentric | Series D | $220M |
| 16 Oct 2025 | Tubulis | Series C | $333M |
| 6 May 2024 | Karius | Series C | $100M |
| 23 Aug 2023 | FORE Biotherapeutics | Series D | $75M |
| 8 Jun 2023 | Upstream Bio | Series B | $200M |
| 2 Jun 2022 | Upstream Bio | Series A | $200M |
| 21 Sept 2020 | FORE Biotherapeutics | Series C | $57M |
| 24 Feb 2020 | Karius | Series B | $165M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has HBM Healthcare Investments invested in?
HBM Healthcare Investments has invested in CellCentric, Tubulis, Karius, FORE Biotherapeutics, Upstream Bio and 4 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for HBM Healthcare Investments:
